Skip to content
DataLookout
Menu

RAPID-uCRLMNCT07919951

RAPID for Unresectable Colorectal Liver Metastases

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

2-Year Tumor Event-Free Survival Rate
Timeframe: From Stage 1 surgery to tumor progression, recurrence, or death from any cause, assessed up to 2 years after Stage 1 surgery

Secondary (2)

Incidence of Major Perioperative Complications (Clavien-Dindo Grade ≥IIIa)
Stage 2 Completion Rate

Arms and interventions

RAPID ProcedureExperimental

All enrolled participants receive the RAPID procedure, a two-stage surgical intervention. Stage 1: partial hepatectomy to remove the tumor-bearing portion of the liver, preserving the remaining native liver as temporary metabolic support; orthotopic implantation of a small-for-size liver graft; ligation of the portal vein supplying the preserved native liver to redirect portal flow to the graft, with preservation of the hepatic artery supplying the preserved native liver. Stage 2: completion hepatectomy to remove the remnant native liver after adequate graft hypertrophy (graft GRWR ≥0.8% and MDT confirmation).

Procedures: RAPID Procedure

Sites

1 site in 1 country

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityGuangzhou, Guangdong, China